Cargando…

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

BACKGROUND: Apolipoprotein D (ApoD) has been proposed as a predictor of breast cancer recurrence among estrogen receptor-positive (ER+), tamoxifen-treated patients. METHODS: We conducted a population-based case-control study nested in a population of 11,251 women aged 35–69 years at diagnosis with S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klebaner, Daniella, Hamilton-Dutoit, Stephen, Ahern, Thomas, Crawford, Anatasha, Jakobsen, Thomas, Cronin-Fenton, Deirdre P., Damkier, Per, Janssen, Emiel, Kjaersgaard, Anders, Ording, Anne Gulbech, Søiland, Håvard, Sørensen, Henrik Toft, Lash, Timothy L., Hellberg, Ylva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354364/ https://www.ncbi.nlm.nih.gov/pubmed/28301514 http://dx.doi.org/10.1371/journal.pone.0171453

Ejemplares similares

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset
por: Damkier, Per, et al.
Publicado: (2017)

Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark
por: Collin, Lindsay J, et al.
Publicado: (2018)

Challenges in translating endpoints from trials to observational cohort studies in oncology
por: Ording, Anne Gulbech, et al.
Publicado: (2016)

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
por: Egeland, Nina G., et al.
Publicado: (2015)

Hospital Recorded Morbidity and Breast Cancer Incidence: A Nationwide Population-Based Case-Control Study
por: Ording, Anne Gulbech, et al.
Publicado: (2012)

Assessing Techniques for Quantifying the Impact of Bias Due to an Unmeasured Confounder: An Applied Example
por: Barberio, Julie, et al.
Publicado: (2021)

Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark
por: Hjorth, Cathrine Fonnesbech, et al.
Publicado: (2021)

Correction: Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark
por: Hjorth, Cathrine Fonnesbech, et al.
Publicado: (2023)

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark
por: Hjorth, Cathrine F., et al.
Publicado: (2022)

Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue
por: Ahern, Thomas P, et al.
Publicado: (2010)

Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study
por: Collin, Lindsay J., et al.
Publicado: (2021)

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
por: Lash, T L, et al.
Publicado: (2008)

Improving the transparency of meta-analyses with interactive web applications
por: Ahern, Thomas P, et al.
Publicado: (2021)

Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs
por: Ording, Anne Gulbech, et al.
Publicado: (2013)

Emerging Concepts of Apolipoprotein D with Possible Implications for Breast Cancer
por: Søiland, Håvard, et al.
Publicado: (2007)

The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer
por: Hjorth, Cathrine F., et al.
Publicado: (2023)

Comorbidity and survival of Danish breast cancer patients from 2000–2011: a population-based cohort study
por: Ording, Anne Gulbech, et al.
Publicado: (2013)

Comorbid Diseases Interact with Breast Cancer to Affect Mortality in the First Year after Diagnosis—A Danish Nationwide Matched Cohort Study
por: Ording, Anne Gulbech, et al.
Publicado: (2013)

Manganese Superoxide Dismutase and Breast Cancer Recurrence: A Danish Clinical Registry-Based Case-Control Study, and a Meta-Analysis
por: Cronin-Fenton, Deirdre P., et al.
Publicado: (2014)

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
por: Helland, Thomas, et al.
Publicado: (2017)

Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer
por: Helland, Thomas, et al.
Publicado: (2021)

Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort study
por: Ording, Anne Gulbech, et al.
Publicado: (2014)

Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
por: Chen, Yuanhuang, et al.
Publicado: (2021)

Long-term mortality in young and middle-aged adults hospitalised with chronic disease: a Danish cohort study
por: Skajaa, Nils, et al.
Publicado: (2020)

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment
por: Lien, Ernst A., et al.
Publicado: (2013)

Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study
por: Gärtner, Rune, et al.
Publicado: (2010)

Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study
por: Sørensen, Gitte Vrelits, et al.
Publicado: (2012)

Evaluation of Hospital-Based Hematuria Diagnosis and Subsequent Cancer Risk Among Adults in Denmark
por: Nørgaard, Mette, et al.
Publicado: (2018)

Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer
por: Søgaard, Mette, et al.
Publicado: (2016)

The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells
por: Helland, Thomas, et al.
Publicado: (2015)

Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
por: Harborg, Sixten, et al.
Publicado: (2020)

Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer
por: Maliniak, Maret L., et al.
Publicado: (2021)

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
por: Helland, Thomas, et al.
Publicado: (2020)

Obesity and Risk of Recurrence in Patients With Breast Cancer Treated With Aromatase Inhibitors
por: Harborg, Sixten, et al.
Publicado: (2023)

Plasma Vitamin B12 Levels, High-Dose Vitamin B12 Treatment, and Risk of Dementia
por: Arendt, Johan Frederik Håkonsen, et al.
Publicado: (2021)

Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study
por: Harborg, Sixten, et al.
Publicado: (2021)

Methods and rationale used in a matched cohort study of the incidence of new primary cancers following prostate cancer
por: Cronin-Fenton, Deirdre P, et al.
Publicado: (2013)

Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort
por: Ahern, Thomas P, et al.
Publicado: (2016)

Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study
por: Cronin-Fenton, Deirdre P, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bi2qhcuq0vl4qk6n384qm7geh3